Form 4: Carisma Therapeutics Inc. Director John Hohneker Acquires Stock Options
SEC Form 4 Filing
Director John Hohneker reports acquisition of stock options in Carisma Therapeutics Inc.
Summary
- On June 26, 2024, John Hohneker, a director of Carisma Therapeutics Inc. (CARM), acquired 19,350 stock options.
- The exercise price of these options is $1.22.
- The options vest on the first anniversary of the grant date or immediately before the first annual meeting of stockholders after the grant date, contingent on continued service as a director.
- The expiration date for these options is June 26, 2034.
- Following the transaction, Hohneker directly owns 19,350 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard Form 4 filing indicating a director's acquisition of stock options, which can be seen as a slightly positive sign of confidence, but it's not a major event.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 06/26/2024 | Date of the transaction: John Hohneker acquired stock options. |
| 06/26/2024 | Grant date of the stock options. |
| 06/26/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.